Le Lézard
Classified in: Health, Science and technology
Subject: AWD

symplr is Recognized as a 2024 U.S. Best Managed Company


Award recognizes symplr's excellence in strategy, execution, culture, governance, and financial performance.

HOUSTON, May 6, 2024 /PRNewswire-PRWeb/ -- symplr®, a leading provider of enterprise healthcare operations software, today announced it has been selected as a 2024 U.S. Best Managed company. Now in its fifth year, the award, sponsored by Deloitte and The Wall Street Journal, recognizes the achievements of an elite group of U.S. private companies and the success of their management teams.

"It is an honor to be named a U.S. Best Managed Company, which is a reflection of our team's hard work, our culture of excellence, and our unwavering commitment to supporting our customers," said BJ Schaknowski, symplr CEO.

"It is an honor to be named a U.S. Best Managed Company, which is a reflection of our team's hard work, our culture of excellence, and our unwavering commitment to supporting our customers," said BJ Schaknowski, symplr CEO. "This further validates how our strategy and people come together to set us apart as one of the best ? in places to work, in innovation, and as a partner to drive meaningful change in healthcare."

U.S. Best Managed Companies is part of the global Deloitte Private program. Honorees are selected by an external panel of judges who evaluate applicants based on strategy, ability to execute, culture, governance, and financial performance. They join an ecosystem of organizations from more than 44 countries.

About symplr?
symplr is a leader in enterprise healthcare operations software and services. Trusted by leaders for more than 30 years, our solutions are found in 9 of 10 U.S. hospitals where our cloud-based solutions drive better operations for better outcomes. Our provider data management, workforce management, compliance, quality and safety, and contract and supplier management solutions improve the efficiency and efficacy of healthcare operations. This enables caregivers to quickly handle administrative tasks, so they have more time to do what they do best: provide high-quality patient care. Learn how at?http://www.symplr.com.??

About the Best Managed Companies Program
The Best Managed Companies program is a mark of excellence for private companies. U.S. designees have revenues of at least $250 million. Thousands of private companies around the world have competed for this designation in their respective countries through a rigorous and independent process that evaluates four key criteria in their management skills and practices ? strategy, execution, culture, and governance/financials. For more information, visit http://www.usbestmanagedcompanies.com.

Media Contact

Ashley Richardson, symplr, 617-275-6519, [email protected], https://www.symplr.com/

Twitter

SOURCE symplr


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: